Effectiveness of zonisamide in a patient with Parkinson's disease and various levodopa-induced psychotic symptoms

被引：3

作者：

Yabe, Ichiro ^{[1
]}

Ohta, Midori ^{[2
]}

Egashira, Toshiaki ^{[3
]}

Sato, Kazunori ^{[1
]}

Kano, Takahiro ^{[1
]}

Hirotani, Makoto ^{[1
]}

Kunieda, Yasuyuki ^{[4
]}

Sasaki, Hidenao ^{[1
]}

机构：

[1] Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan

[2] Wakkanai City Hosp, Rehabil Ctr, Wakkanai, Hokkaido, Japan

[3] Wakkanai City Hosp, Dept Psychiat, Wakkanai, Hokkaido, Japan

[4] Wakkanai City Hosp, Dept Internal Med, Wakkanai, Hokkaido, Japan

来源：

NEUROLOGY AND CLINICAL NEUROSCIENCE | 2014年 / 2卷 / 06期

关键词：

dopamine agonists; levodopa; Parkinson's disease; psychotic symptoms; zonisamide;

D O I：

10.1111/ncn3.126

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Levodopa and dopamine agonists are useful as Parkinson's disease medications. However, they often induce persistent psychotic symptoms and motor complications, which make Parkinson's disease treatment difficult. This is a case report of a patient with advanced Parkinson's disease accompanied by exacerbation of motor symptoms and psychotic symptoms derived from prolonged use of conventional anti-Parkinson's disease drugs, and in whom adjunctive therapy with a new anti Parkinson's disease drug, zonisamide, was shown to improve motor symptoms with no exacerbation of psychotic symptoms.

引用

页码：201 / 203

页数：3

共 50 条

[1] Levodopa-Induced Hyperventilation Observed in a Parkinson's Disease Patient
Hattori, Anri
Tsunemi, Taiji
Shimada, Tomoyo
Nakagawa, Emi
Hattori, Nobutaka
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2020, 47 (01) : 137 - 138
[2] CARDINAL SYMPTOMS OF PARKINSON'S DISEASE COHABIT WITH LEVODOPA-INDUCED DYSKINESIA
Goubault, E.
Nguyen, H. P.
Bogard, S.
Faucher, G.
Duval, C.
PARKINSONISM & RELATED DISORDERS, 2018, 46 : E12 - E12
[3] Levodopa-induced dyskinesia in Parkinson's disease
Brotchie, JM
Lee, J
Venderova, K
JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (03) : 359 - 391
[4] Levodopa-induced migraine in Parkinson's disease
Gunzler, S. A.
MOVEMENT DISORDERS, 2013, 28 : S208 - S208
[5] Levodopa-induced hyperhomocysteinaemia in Parkinson's disease
Yasui, K
Nakaso, K
Kowa, H
Takeshima, T
Nakashima, K
ACTA NEUROLOGICA SCANDINAVICA, 2003, 108 (01): : 66 - 67
[6] Levodopa-induced dyskinesia in Parkinson’s disease
J. M. Brotchie
J. Lee
K. Venderova
Journal of Neural Transmission, 2005, 112 : 359 - 391
[7] Contralateral levodopa-induced hemichorea in a patient with severe asymmetric Parkinson's disease
Yoo, Sang-Won
Kim, Joong-Seok
ACTA NEUROLOGICA BELGICA, 2020, 120 (03) : 691 - 693
[8] Contralateral levodopa-induced hemichorea in a patient with severe asymmetric Parkinson’s disease
Sang-Won Yoo
Joong-Seok Kim
Acta Neurologica Belgica, 2020, 120 : 691 - 693
[9] Propofol Withdrawal Dyskinesia in a Parkinson's Disease Patient with Levodopa-Induced Dyskinesia
Nakajima, Asuka
Iwamuro, Hirokazu
Tokugawa, Joji
Odo, Masahiko
Shimo, Yasushi
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2023, 50 (02) : 322 - 323
[10] Management of levodopa-induced dyskinesias in Parkinson's disease
Kashihara, Kenichi
JOURNAL OF NEUROLOGY, 2007, 254 (Suppl 5) : 27 - 31

← 1 2 3 4 5 →